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Although information about seasonality and prevalence 
of inﬂ  uenza is crucial for development of effective preven-
tion and control strategies, limited data exist on the epidemi-
ology of inﬂ  uenza in tropical countries. To better understand 
inﬂ  uenza in Nicaragua, we performed a prospective 2-year 
cohort study of inﬂ   uenza-like illness (ILI) involving 4,276 
children, 2–11 years of age, in Managua, during April 2005–
April 2007. One peak of ILI activity occurred during 2005, in 
June–July; 2 peaks occurred during 2006, in June–July and 
November–December. The rate of ILI was 34.8/100 person-
years. A household risk factor survey administered to a sub-
set (61%) of participants identiﬁ  ed the following risk factors: 
young age, asthma, and increasing person density in the 
household. Inﬂ  uenza virus circulation was conﬁ  rmed during 
each ILI peak by laboratory testing of a subset of samples. 
Our ﬁ  ndings demonstrate a high rate of ILI, with seasonal 
peaks, in children in Nicaragua.
I
nﬂ  uenza is a major health threat throughout the world, 
causing substantial illness and death each year (1). In 
temperate regions, the epidemiology and prevalence of 
inﬂ  uenza have been the topic of extensive investigation. 
However, data on the epidemiology of inﬂ  uenza in tropical 
countries are limited (2,3). Information concerning season-
ality and prevalence is crucial for development of effective 
regional and global seasonal inﬂ  uenza prevention strate-
gies as well as pandemic inﬂ  uenza control measures (3,4). 
This scarcity of data can be attributed to limited laboratory 
resources and capabilities, as well as to the lower priority 
given to inﬂ  uenza compared with other infectious diseases 
in these regions. Furthermore, among the small body of 
evidence that does exist about inﬂ  uenza in the tropics, in-
sufﬁ  cient data have been reported on its seasonality. Sever-
al studies have reported no deﬁ  ned inﬂ  uenza season (5–7), 
some have reported that inﬂ  uenza seasonality coincides 
with the rainy season (8–10), and others have reported 1 or 
2 seasonal peaks of inﬂ  uenza activity per year (11–13).
In the absence of laboratory conﬁ  rmation, potential 
inﬂ  uenza cases can be identiﬁ  ed with a clinical deﬁ  nition 
of inﬂ  uenza, inﬂ  uenza-like illness (ILI). However, mul-
tiple respiratory viruses, including respiratory syncytial 
virus, parainﬂ  uenza viruses, adenovirus, and rhinovirus, 
can cause similar signs and symptoms (14). Among these 
viruses, only respiratory syncytial virus causes seasonal 
epidemic peaks in children. Because respiratory syncytial 
virus is most common in children <5 years of age, limit-
ing the analysis to children >5 years of age can increase 
the probability that a peak in ILI is due to inﬂ  uenza virus 
(15,16). In addition, ILI has been shown to be more spe-
ciﬁ  c for inﬂ  uenza when inﬂ  uenza virus is circulating in an 
area (17). Finally, a more speciﬁ  c clinical deﬁ  nition can be 
used to increase the likelihood that ILI cases are inﬂ  uenza. 
Despite the absence of 1 commonly accepted deﬁ  nition for 
high-probability ILI, using a deﬁ  nition of fever >38.2°C 
with cough has been found to have a high positive predic-
tive value (83%) for laboratory-conﬁ  rmed inﬂ  uenza (18). 
To study inﬂ  uenza in Nicaragua, a developing country in 
Central America, we conducted a cohort study to evaluate 
the prevalence and seasonal pattern of ILI and its associ-
ated risk factors among children.
Materials and Methods
Study Site
Managua is the capital of Nicaragua and the largest city 
in the country; its estimated population is 1.4 million. The 
Health Center Sócrates Flores Vivas (HCSFV), a public pri-
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mary care facility located in District II of Managua, served as 
the study site. HCSFV provides medical care for the ≈62,500 
persons who reside in the surrounding catchment area.
Study Population
We used information collected through the Nicaraguan 
Pediatric Dengue Cohort Study, a prospective cohort study 
established in August 2004 to study pediatric dengue infec-
tion. Recruitment of children 2–9 years of age was con-
ducted by door-to-door visits in neighborhoods served by 
HCSFV. Children were ineligible to participate if their par-
ents or guardians reported a history of any disease or treat-
ment that might suppress the immune system, such as HIV/
AIDS or treatment for cancer. To maintain the age structure 
of the cohort, during July and August of each year, addi-
tional participants 2 years of age were enrolled. Age range 
by the end of the 2-year study was 2–11 years. All partici-
pants were provided medical treatment and tests by study 
physicians at HCSFV free of charge, 24 hours per day, 365 
days per year. A study ambulance was available at all times 
to transfer any child requiring hospitalization or emergency 
services not available at HCSFV. To determine the percent-
age of children who did not regularly attend HCSFV when 
ill and to encourage attendance, home visits were conduct-
ed at least 1 time per year. All children were contacted by 
study medical personnel each year during July or August; 
if the child could not be located after at least 3 attempts, the 
child was considered lost to follow-up. 
Our analysis covered 2 years, from April 16, 2005, 
through April 15, 2007. As a part of the study enrollment 
process, study personnel used questionnaire forms that 
asked questions in a systematic way to gather demographic 
information and medical history. Subsequently, a house-
hold risk-factor questionnaire was administered at home 
visits and at HCSFV; children with completed household 
risk-factor questionnaires at the beginning or during the 
ﬁ  rst few months of the time period analyzed in this study 
were selected as the convenience sample. The study was 
approved by the institutional review boards at the Univer-
sity of California at Berkeley and the Nicaraguan Ministry 
of Health. Informed consent was obtained from the parent 
or legal guardian of each participant, and participants >6 
years of age completed assent procedures.
Surveillance and Case Deﬁ  nition
Parents or guardians agreed to bring participants to 
HCSFV at the ﬁ  rst sign of fever and for all medical appoint-
ments. Medical information from all visits was recorded 
on forms for systematic data collection at the time of con-
sultation. The Centers for Disease Control and Prevention 
(CDC) deﬁ  nition of inﬂ  uenza-like illness was used: fever 
>37.8°C at presentation with a cough and/or sore throat. 
ILI episodes were considered to be the same episode if they 
occurred within a week of each other, if they had the same 
date of fever onset, or if the physician denoted them as a 
continuing illness. High-probability ILI was deﬁ  ned as a 
fever >38.2°C at presentation with a cough (18). To elimi-
nate the younger ages in which respiratory syncytial virus, 
a common seasonal respiratory virus, is often prevalent, a 
portion of the analysis was restricted to children >6 years 
of age (15,16).
Laboratory Methods
Paired serum samples were collected for a subset of 
participants during each peak of ILI activity (11 paired 
samples from the 2005 peak, 15 from each of the 2 peaks 
in 2006, and 10 from nonpeak periods of each year); the 
ﬁ  rst sample was collected at the initial visit, and the sec-
ond was collected 2–4 weeks later. The hemagglutination 
inhibition test was performed by using the standardized re-
agents and protocols provided by the World Health Orga-
nization. Results were considered positive for inﬂ  uenza if 
a >4-fold rise in hemagglutination inhibiting antibody titer 
was noted between acute- and convalescent-phase samples. 
During December 2006–January 2007, a total of 51 nasal 
and throat swab samples were collected and analyzed by re-
verse transcriptase–PCR (RT-PCR). Swabs were collected 
from children who had fever or a history of fever and cough 
and/or sore throat and symptoms for <5 days. RNA was 
extracted from 140 μL of viral transport medium contain-
ing the swabs by using the QIAamp Viral RNA Isolation 
Kit (QIAGEN, Valencia, CA, USA) and ampliﬁ  ed by us-
ing the Access RT-PCR System (Promega, Madison, WI, 
USA); primers were directed to inﬂ  uenza A and inﬂ  uenza 
B viruses according to the standard operating procedure of 
CDC’s Inﬂ  uenza Branch.
Statistical Methods
Total person-time was determined by the amount of 
time that a participant was enrolled in the cohort. For those 
lost to follow-up, person-time was determined by adding 
the known person-time between enrollment or the begin-
ning of the study period and last contact with the study to 
half the amount of time between the last contact with the 
participant and the ofﬁ  cial loss date. Incidence was calcu-
lated as the number of ILI episodes divided by the person-
time multiplied by 100. A Poisson distribution was used to 
calculate 95% conﬁ  dence intervals (CIs) for the incidence 
rates. Weekly incidence was graphed and smoothed by us-
ing Lowess (19) with a 3-week moving average. Incidence 
rate ratios (IRRs) were used as the measure of relative risk. 
General estimating equations with a Poisson distribution 
were used to estimate IRRs. General estimating equations 
were chosen to account for the longitudinal nature of the 
study; most participants contributed 2 person-years of time. 
To check the assumption that the ILI events were uncor-
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related, the models were also run with a negative binomial 
distribution; however, the results did not signiﬁ  cantly dif-
fer from those of the models with a Poisson distribution, 
and therefore the Poisson distribution was used in all mod-
els. Robust standard errors with an exchangeable correla-
tion structure were used to estimate the 95% CIs for IRRs. 
Model selection was performed by using a backward step-
wise procedure. The χ2 test was used to compare propor-
tions. All analysis was conducted using STATA version 
9.2 (STATA Corp, College Station, TX, USA).
Results
Demographic Characteristics
A total of 4,276 children contributed 7,449 person-
years of time to the study. Of these, 3,240 (75.8%) children 
contributed 2 full years of time, 555 (13%) 2-year-old chil-
dren were enrolled during yearly maintenance enrollment, 
118 (2.8%) children were withdrawn from the study, and 
363 (8.5%) were lost to follow-up. Children were with-
drawn from the study if their parents requested it, if they 
moved from the study area, or if they did not follow study 
procedures. Cohort characteristics are summarized in Table 
1. Attendance at HCSFV was high; 83.3% of participants 
had >1 medical visit, and 94.1% of those with fever visited 
HCSFV by the fourth day after fever onset. At the time 
of home visits, only 1.9% of participants reported having 
sought medical care outside of the cohort.
Incidence of ILI
A total of 2,596 episodes of ILI yielded an incidence 
rate of 34.8 episodes per 100 person-years (95% CI 33.5–
36.2). Decreasing incidence was noted for each 1-year in-
crease in age (Figure 1). Rates for boys and girls did not 
differ signiﬁ  cantly (Table 2). Of the participants, 38% had 
had >1 episode of ILI; of those with ILI, the mean number 
of ILI episodes per child was 1.6 (range 1–8). Among chil-
dren with ILI, the rate of hospital transfer for evaluation 
and possible admission was 14 per 1,000 person-years.
ILI episodes occurred with marked seasonality; they 
peaked during June–July in both years and again during 
November–December of the second year (Figure 2, panel 
A). The same pattern was present when a high probabil-
ity of inﬂ  uenza deﬁ  nition was used (fever >38.2°C with 
cough) and when the analysis was restricted to children 
>6 years of age (Figure 2, panels B and C). Analysis of a 
subset of paired serum samples under each peak showed 
that all 3 peaks were likely due, at least in part, to inﬂ  u-
enza; 64% of the June 2005 peak samples were positive 
for inﬂ  uenza A virus (H3N2), 27% of the June 2006 peak 
samples were positive for inﬂ  uenza B virus, and 20% of 
the November–December 2006 peak samples were positive 
for inﬂ  uenza A virus (H1N1) and 7% for inﬂ  uenza B. All 
samples from nonpeak times were negative for inﬂ  uenza 
A and B viruses. RT-PCR of 51 samples from the Novem-
ber–December 2006 peak conﬁ  rmed the hemagglutination 
inhibition results: 10 (20%) were positive for inﬂ  uenza A 
virus. Conversely, no inﬂ  uenza B virus-positive samples 
were identiﬁ  ed among the samples collected in June 2005, 
and no inﬂ  uenza A virus (H3N2)–positive samples were 
detected in November–December 2006.
Demographic and Medical Risk Factors
Demographic and medical risk factor information was 
available for all cohort participants. Young age was the 
strongest predictor of ILI; risk decreased with each increas-
ing year of age (Table 3). Having received a prior diagno-
sis of asthma was a strong predictor of ILI; risk was 1.79 
times higher for children with asthma (95% CI 1.56–2.06) 
than for other children, after adjusting for age and sex. No 
410  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 15, No. 3, March 2009
Table 1. Baseline characteristics of cohort of children 2–11 years of age, Managua, Nicaragua, 2005–2007 
Characteristic
All cohort participants,
no. (%), n = 4,276 
Participants who completed household survey,  
no. (%), n = 2,615 p value*
Sex 0.731
  F 2,114 (49.4) 1,304 (49.9)
 M 2,162 (50.6) 1,311(50.1)
Age, y <0.001
  2 755 (17.7) 566 (21.6)
 3 473 (11.0) 330 (12.6)
 4 539 (12.6) 348 (13.3)
 5 504 (11.8) 317 (12.1)
 6 453 (10.6) 253 (9.7)
 7 462 (10.8) 263 (10.1)
 8 460 (10.8) 227 (8.7)
 9 413 (9.7) 207 (7.9)
 10 217 (5.1) 104 (4.0)
Asthma 0.001
  Yes 259 (6.1) 213 (8.1)
  No  4,276 (94.0)  2,402 (91.8) 
*Determined by Ȥ
2 test.  Inﬂ  uenza-like Illness in Children, Nicaragua
signiﬁ  cant difference in the risk for ILI was noted between 
boys and girls.
Household Risk Factors
Information concerning socioeconomic and household 
risk factors (hereafter referred to as household factors) 
was available for 2,615 (61%) participants (Table 1). The 
cohort and the subset of children sampled for household 
factors were similar with regard to sex distribution but dif-
fered slightly in age distribution and asthma status. Neigh-
borhood geographic distribution of the entire cohort and 
of those with household risk factor data did not differ sig-
niﬁ  cantly (p = 0.98). Socioeconomic information on those 
surveyed is shown in Table 4. Household factors collected 
and included in the model were number of people living in 
the house, person density (determined by number of people 
living in the household divided by the number of rooms), 
mother’s literacy status, mother’s educational level, type 
of ﬂ  oor, and presence of a toilet or latrine. Electricity and 
running water in the house were not included in the model 
because >99% of the cohort had access to each (at least 
some of the time). The ﬁ  nal model contained person den-
sity in the household, mother’s literacy status, type of ﬂ  oor, 
and the child’s age, asthma status, and sex (Table 5). A 
trend of increasing risk for ILI was noted with increasing 
person density in the household; homes with 3.0–4.9 per-
sons per room had an RR of 1.07 (95% CI 0.96–1.20), and 
those with >5 persons per room had an RR of 1.18 (95% 
CI 1.04–1.34) compared with households with <3 persons 
per room. Having a literate mother was protective against 
ILI (RR 0.79; 95% CI 0.64–0.98). Although not retained in 
the ﬁ  nal model, in the univariate analysis the mother’s edu-
cational level displayed a U-shaped pattern; risk decreased 
until completion of primary school and then increased with 
completion of secondary school or college.
Discussion
We have documented a substantial amount of illness 
and the seasonal variation of ILI in a large cohort of children 
in Nicaragua, a tropical developing country. A high level 
of ILI (34.8 episodes/100 person-years) was found for all 
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Figure 1. Age-stratiﬁ   ed incidence (cases/100 person-years) of 
inﬂ   uenza-like illness in cohort of children 2–11 years of age in 
Nicaragua. Error bars indicate SEM.
Table 2. Incidence of influenza-like illness in cohort of children 2–11 years of age, Managua, Nicaragua, 2005–2007* 
Characteristic Person-years, %† ILI episodes‡ Incidence/100 person-years 95% CI
All participants 7,449.4 2,596 34.8 33.5–36.2
Year
 2005–2006§ 3,704.5 1,106 29.9 28.1–31.7
 2006–2007¶ 3,745.0 1,490 39.8 37.8–41.9
Sex
 M 3,778.7 1,280 33.9 32.1–35.8
 F 3,670.7 1,316 35.9 34.0–37.8
Age, y
 2 339.2 285 84.0 74.8–94.4
 3 721.8 475 65.8 60.2–72.0
 4 871.1 418 48.0 43.6–52.8
 5 931.6 342 36.7 33.0–40.8
 6 916.3 287 31.3 27.9–35.2
 7 854.2 252 29.5 26.1–33.4
 8 852.7 181 21.2 18.3–24.6
 9 815.0 172 21.1 18.2–24.5
 10 709.5 122 17.2 14.4–20.5
 11 438.0 62 14.2 11.0–18.2
Asthma
 Yes 447.8 322 71.9 64.5–80.2
 No  7,001.7 2,274 32.5 31.2–33.8
*ILI, influenza-like illness; CI, confidence interval. 
†Person-years were determined by dividing the total number of person-weeks by 52. 
‡ILI was defined as an acute fever >37.8°C with cough or sore throat. 
§April 16, 2005–April 15, 2006. 
¶April 16, 2006–April 15, 2007. RESEARCH
age groups. Incidence was highest for those 2 years of age 
(84.0 episodes/100 person-years) and decreased with each 
age increase of 1 year. Furthermore, a seasonal pattern in 
ILI activity was noted; a peak occurred during June–July in 
each of the 2 years of the study. Additionally, in the second 
year, a second peak of ILI was documented during Novem-
ber–December; thus, Nicaragua may experience 2 peaks of 
inﬂ  uenza activity in some years. The hypothesis that the 
observed peaks of ILI are due to inﬂ  uenza is supported by 
the seasonal pattern of high-probability ILI, ILI in children 
older than 6 years (who are less likely to have respiratory 
syncytial virus infections) (15), and laboratory results.
Risk factor analysis showed that young age and asthma 
status were strong risk factors for ILI, consistent with what 
has been found in other studies (20,21). Person-density in 
the house was positively associated with risk for ILI. Al-
though children in households with 3.0–4.9 residents per 
room had an elevated risk that did not achieve statistical 
signiﬁ   cance, those in households with >5 residents per 
room displayed a signiﬁ  cantly increased risk for ILI. In a 
study of acute respiratory infection in children in Green-
land, nighttime crowding (i.e., sharing a room at night) was 
signiﬁ  cantly associated with the risk for acute respiratory 
infections, but general crowding (i.e., number of persons/
room) as measured in this study, was not (22). Several stud-
ies in developing countries have yielded mixed results con-
cerning the association between household crowding and 
acute respiratory infection, but most report no association 
(23). Our study found that maternal literacy was protective 
for ILI but that the mother’s education level was not sig-
niﬁ  cantly associated. Although not signiﬁ  cant in the ﬁ  nal 
model, the mother’s education level showed a U-shaped 
relationship, perhaps because of a higher likelihood that 
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Figure 2. Incidence (cases/100 person-years) of inﬂ  uenza-like 
illness (ILI) in a cohort of children in Nicaragua, showing seasonal 
peaks, April 16, 2005–April 15, 2006, and April 16, 2006–April 15, 
2007. A) Incidence of ILI episodes per calendar week. B) Incidence 
of high-probability ILI episodes per calendar week. C) Incidence of 
ILI in children 6–12 years of age per calendar week. All curves were 
smoothed by Lowess (19) by using a 3-week moving average.
Table 3. Risk factors for influenza-like illness in cohort of 4,276 children 2–11 years of age, Managua, Nicaragua, 2005–2007* 
Characteristic Crude RR† 95% CI Adjusted RR†‡ 95% CI
Sex
 M 0.94 0.85–1.04 0.95 0.87–1.04
 F Ref Ref
Age, y
 2 5.94 4.49–7.85 5.53 4.19–7.32
 3 4.67 3.56–6.12 4.39 3.35–5.75
   4 3.46 2.63–4.54 3.29 2.51–4.32
 5 2.67 2.03–3.53 2.58 1.96–3.41
 6 2.30 1.74–3.03 2.24 1.70–2.95
 7 2.13 1.61–2.83 2.09 1.58–2.77
 8 1.52 1.12–2.04 1.49 1.11–2.01
 9 1.51 1.13–2.03 1.50 1.12–2.01
 10 1.23 0.91–1.67 1.23 0.91–1.66
 11 Ref Ref
Asthma
 Yes  2.23 1.92–2.59 1.79 1.56–2.06
 No  Ref Ref
*RR, relative risk; CI, confidence interval; Ref, reference. 
†The measure of RR used is the incidence rate ratio. 
‡Multivariate model included sex, age, and asthma status.  Inﬂ  uenza-like Illness in Children, Nicaragua
mothers with a higher education level work outside of the 
home, necessitating outside childcare. Certainly, this as-
sociation and others need to be examined further. In par-
ticular, including details about childcare (e.g., whether the 
child is cared for outside the home and the type of facility) 
and socioeconomic factors, will be informative. We have 
reﬁ  ned the household questionnaire and will administer it 
on a yearly basis.
Strengths of this study include the large size of the co-
hort, its prospective nature, and high compliance with study 
procedures. In addition, the study had a high rate of follow-
up; only 11.3% of the children were either withdrawn or 
lost to follow-up. Children who were censored from the 
analysis do not appear to have differed from those who 
completed the 2-year period (data not shown); thus, we do 
not believe that our results are biased due to censoring.
One major limitation is that this study used a syndromic 
deﬁ  nition for ILI because specimens to determine causative 
agent were not generally available; because the cohort was 
not initially established to study respiratory diseases, respi-
ratory samples were not collected for most of the study pe-
riod. However, inﬂ  uenza during all 3 peaks of ILI activity 
was conﬁ  rmed by laboratory testing of a subset of samples. 
Additionally, the study relied on enhanced passive surveil-
lance, and thus we cannot be certain that we captured all 
episodes of ILI in the cohort. Nonetheless, compliance with 
study procedures was high; 94% of children visited HCSFV 
by the fourth day of fever, and only 1.9% reported having 
sought medical attention by nonstudy medical personnel. 
However, some mild ILI episodes were likely not detected 
because participants did not seek medical attention. Because 
of the passive nature of the surveillance and the requirement 
for fever, our calculated incidence may underestimate the 
true incidence of ILI in the cohort. Additionally, this study 
covered only a 2-year time period, which limits our ability 
to assess seasonality. Finally, the sample of participants that 
participated in the household survey did differ somewhat 
from the general population, likely because of an increased 
probability of parents of younger children being home in the 
daytime. However, because the geographic distribution of 
participants included in the risk factor analysis did not differ 
signiﬁ  cantly from the distribution of the general cohort and 
because in Nicaragua, neighborhood is strongly associated 
with socioeconomic status and living conditions, it is likely 
that the subset for whom risk factor data were available was 
reasonably representative of the cohort, after age and asth-
ma status were taken into account.
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Table 4. Household characteristics of participants in cohort of 
children 2–11 years of age, Managua, Nicaragua, 2005–2007 
Characteristic
Participants with household data, 
no. (%), n = 2,615
Persons/room
 <3 1,254  (47.6)
 3–4 917  (35.1)
>5 444 (17.0)
Mother literate
 Yes 2,436  (94.4)
 No 146  (5.6)
Mother’s education level
 None 158  (6.1)
 Some  primary 421  (16.1)
 Completed  primary 387  (14.9)
 Some  secondary 1,045  (40.2)
 Completed  secondary 361  (13.9)
 College 225  (8.7)
Type of floor
 Dirt 552  (21.1)
  Concrete or other 2,063 (78.9)
Electricity
 Yes 2,605  (99.9)
 No 3  (0.1)
Sanitation
 None 17  (0.7)
 Latrine 307  (11.7)
 Flushing  toilet 2,291  (87.6)
Access to potable water
 Yes 2,582  (99.4)
   No 16 (0.6)
Table 5. Household risk factors for influenza-like illness in a 
subset of 2,615 children 2–11 years of age, Managua, 
Nicaragua, 2005–2007* 
Characteristic Crude RR† (95% CI) Adjusted RR†‡  (95% CI)
Sex
  M 0.96 (0.87–1.07) 0.98 (0.89–1.07)
 F Ref Ref
Age, y
  2 5.01 (3.63–6.93) 4.83 (3.50–6.66)
  3 4.21 (3.08–5.76) 4.07 (2.98–5.56)
  4 3.13 (2.29–4.30) 3.05 (2.22–4.18)
  5 2.55 (1.85–3.51) 2.51 (1.82–3.45)
  6 2.03 (1.47–2.80) 2.01 (1.46–2.78)
  7 2.01 (1.45–2.80) 2.00 (1.44–2.78)
  8 1.50 (1.06–2.12) 1.49 (1.06–2.10)
  9 1.55 (1.10–2.19) 1.54 (1.09–2.17)
  10 1.25 (0.88–1.77) 1.24 (0.88–1.76)
 11 Ref Ref
Asthma
 Yes  1.83  (1.57–2.13) 1.51  (1.32–1.75)
 No  Ref Ref
Persons/room
 <3 Ref Ref
 3–4 1.04 (0.93–1.17) 1.07 (0.96–1.20)
>5 1.14 (1.00–1.31) 1.18 (1.04–1.34)
Mother literate 
  Yes 0.80 (0.63–1.01) 0.79 (0.64–0.98)
 No Ref Ref
Dirt floor 
  Yes 0.95 (0.84–1.08) 0.88 (0.78–1.00)
 No Ref Ref
*RR, relative risk; CI, confidence interval; Ref, reference. 
†The measure of RR used is the incidence rate ratio. 
‡Multivariate model included sex, age, asthma status, person density in 
house, mother’s literacy, and a dirt floor. RESEARCH
Inﬂ  uenza, in both its epidemic and pandemic forms, 
is a major health threat in tropical regions, just as it is in 
temperate regions. The lack of data on the epidemiology of 
inﬂ  uenza in tropical regions makes it extremely difﬁ  cult for 
nations in these areas to plan for and prevent inﬂ  uenza. It 
also hampers attempts at modeling pandemic inﬂ  uenza and 
development of appropriate control strategies. Results from 
this initial study of pediatric ILI in Nicaragua document a 
high level of disease and demonstrate pronounced seasonal 
peaks. Risk factors were young age, an asthma diagnosis, 
and high person-density in the house; a protective factor 
was having a literate mother.
A prospective study of inﬂ  uenza in the Nicaraguan pe-
diatric cohort in which respiratory samples will be tested 
for inﬂ  uenza is currently under way. This study should fur-
ther characterize the epidemiology of inﬂ  uenza and analyze 
the nucleotide sequence variation and the relationship of 
inﬂ  uenza viruses circulating in the cohort to those isolated 
in the Northern and Southern Hemispheres. Further studies, 
particularly with laboratory-conﬁ  rmed outcomes, in mul-
tiple countries, are needed to conﬁ  rm the seasonality and 
level of inﬂ  uenza in the tropics.
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